• Ebola update: New research sheds light on origin, transmission of Sierra Leone outbreak

    Haley Bridger, September 2nd, 2014 | Filed under

    Researchers from the Broad Institute have been working with a team of international collaborators to collect samples, rapidly sequence genomes, and share data in order to accelerate response efforts to the ongoing outbreak of Ebola in West Africa. The team’s efforts culminate with a paper published online in the journal Science, but the story of their research and collaboration stretches back many years.

    Read More
  • Broad in the news: New York Times covers landmark heart disease study by Broad researchers and colleagues

    Haley Bridger, June 27th, 2014 | Filed under

    By scouring the DNA of thousands of patients, researchers at the Broad Institute and Massachusetts General Hospital and their colleagues have discovered four rare mutations in the gene APOC3 that lower triglycerides and reduce a person’s risk of coronary heart disease — dropping it by 40 percent.

    Read More
  • Glioblastoma’s “stem-like” cells laid bare

    Haley Bridger, April 10th, 2014

    What: Glioblastoma, the most common and most aggressive form of brain cancer in adults, remains effectively incurable. Evidence suggests that “stem-like” cells help drive this difficult-to-treat disease. These cells may possess properties that give them the ability to resist treatment and drive cancer’s growth, but pinpointing them and understanding the circuitry that makes them behave the way they do has been a major challenge.

    Read More
  • Insights into drug resistance for a rare leukemia

    Haley Bridger, March 3rd, 2014

    What: For patients with T cell acute lymphoblastic leukemia (T-ALL), a rare form of blood cancer that mainly affects children and young adults, drug resistance poses a major threat to a promising treatment option currently in clinical trials. About half of patients with T-ALL have mutations in NOTCH1, but drugs that target this gene have so far produced only short-lived effects: at first, the cancer seems to respond, but in a short period of time, T-ALL returns.

    Read More
  • Holiday closing from Dec. 23, 2013 to Jan. 1, 2014

    Haley Bridger, December 6th, 2013

    To give employees ample time to celebrate the holidays with friends and family, the Broad Institute will close from Monday, December 23, 2013 to Wednesday, January 1, 2014. It will reopen on Thursday, January 2, 2014.

    Our websites, of course, will still be up and running during the closing, allowing researchers all over the globe to continue accessing data, software, tools, and more.

    Read More
  • Insights into OCD and Tourette syndrome

    Haley Bridger, October 28th, 2013

    What: Researchers are beginning to probe the underlying genetic basis of obsessive compulsive disorder (OCD) and Tourette syndrome (TS), two neuropsychiatric disorders that frequently co-occur in families.

    Read More
  • Broad’s websites will be unavailable Oct. 17 – 20

    Haley Bridger, October 8th, 2013

    Upddate, Oct. 20: We're happy to report that our IT team has made impressive progress over the weekend and our external facing web pages are now back up and running. For updates on other services, please follow the tweets from @broadsystems.

    Read More
  • Feng Zhang makes MIT Technology Review’s INNOVATORS UNDER 35 List

    Haley Bridger, August 21st, 2013

    Broad Institute core faculty member Feng Zhang has been named to MIT Technology Review’s list of 35 top young investigators in recognition of his work in biotechnology and medicine.

    Read More
  • Feng Zhang receives Vallee Foundation Young Investigator Award

    Haley Bridger, July 24th, 2013

    Broad Institute core faculty member Feng Zhang has been selected as one of the first winners of the Bert L. and N. Kuggie Vallee Foundation Young Investigator Award. The award recognizes outstanding young scientists and provides discretionary funds for basic biomedical research.

    Read More
  • Sneak preview of “The road to vital therapy”

    Haley Bridger, July 5th, 2013

    Midsummer Nights’ Science has become an annual tradition at the Broad Institute, and this year our first lecture in the series offers something extra special: a panel discussion featuring several luminaries from the world of chemical biology and drug discovery. This is the first panel discussion in the history of the series and promises to be a thought-provoking conversation about drug discovery and how we might mitigate suffering from disease in the future.

    Read More